In the present work, we hypothesize that a targeting nanoplatform based on immobilizing AGP into HA NPs (AGP-HA NPs) can suppress the inflammation of tumor cells, leading to the modulation of its MDR, thereby reducing tumor migration. The gene discussed is ATP5MK; the disease is neoplasm.